SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-238472
Filing Date
2017-07-27
Accepted
2017-07-27 16:04:34
Documents
3
Period of Report
2017-07-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d424413d8k.htm 8-K 16304
2 EX-99.1 d424413dex991.htm EX-99.1 87947
3 GRAPHIC g424413g88e44.jpg GRAPHIC 3056
  Complete submission text file 0001193125-17-238472.txt   110083
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-36830 | Film No.: 17986272
SIC: 2834 Pharmaceutical Preparations